FDA Inspection 1154662 — Biomat USA, Inc.
The FDA completed an inspection of Biomat USA, Inc. on September 29, 2021 in Pittsburgh, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 29, 2021
- Fiscal Year
- 2021
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Pittsburgh, PA (United States)